AstraZeneca announced that it has entered an agreement with Grünenthal for the global rights to Zomig (zolmitriptan) outside Japan. Zomig...
Zolmitriptan is indicated for the acute treatment of migraine headache with or without aura. Zolmitriptan Orodispersible Tablets is not indicated for prophylaxis of migraine.